ABOUT NANOPHARM LIMITED
We provide independent and innovative guidance, which is trusted by our clients.
World leading R&D centre in this field, we provide ‘hands-on’ support.
Working with Nanopharm is like recruiting your own specialist respiratory R&D team - enhanced by state-of-the-art technologies and the know-how to develop complex OINDP drug products.
Prof. Robert Price is the founder and hands-on manager of Nanopharm Ltd and has over 15 years experience in research and development of orally inhaled and nasal drug products. He is a Professor of Pharmaceutics at the University of Bath and holds a first-degree in Physics and a PhD in Surface Science. Rob has authored over 100 publications and has invented, developed and licensed novel technologies into the industry.
Dr Jag Shur is a director and hands-on manager of Nanopharm Ltd and has managed business operations and the successful growth of Nanopharm. He has over 15 years of experience in the development of orally inhaled and nasal drug products in both industry and academia, having held positions at Profile Therapeutics (Philips), GlaxoSmithKline and the University of Bath. Jag has a first degree in Chemistry, received his PhD in Inhaled Biopharmaceutics and has authored more than 30 scientific papers.
Nanopharm
We are the world’s leading provider of orally inhaled and nasal drug product design and development services.
We enable the seamless translation of pre-clinical development through to clinical manufacture of OINDPs through our unique processing technologies and formulation development tools. Our integrated development services in materials characterisation, formulation development and inhaled biopharmaceutics aids successful product development of OINDPs by understanding how material properties and processing conditions influence product functionality.
We are the market leaders in providing bespoke solutions to the development of OINDPs. Our technology platforms for advanced materials characterisation, formulation & device development, together with in silico modelling of OINDP in vivo behaviour, is acknowledged as cutting edge and market leading.
Company registration No: 04371441
KEY FINANCES
Year
2016
Assets
£925.65k
▲ £491.07k (113.00 %)
Cash
£478.18k
▲ £234.74k (96.43 %)
Liabilities
£203.38k
▲ £124.38k (157.46 %)
Net Worth
£722.27k
▲ £366.68k (103.12 %)
REGISTRATION INFO
-
Check the company
-
UK
-
Hertsmere
- Company name
- NANOPHARM LIMITED
- Company number
- 04371441
- VAT
- GB928408114
- Status
-
Active
- Categroy
- Private Limited Company
- Date of Incorporation
-
11 Feb 2002
Age - 23 years
- Home Country
- United Kingdom
CONTACTS
- Website
- nanopharm.co.uk
- Phones
-
+44 (0)1633 504 776
01633 504 776
- Registered Address
- FIVEWAYS,
57-59 HATFIELD ROAD,
POTTERS BAR,
HERTFORDSHIRE,
ENGLAND,
EN6 1HS
ECONOMIC ACTIVITIES
- 21200
- Manufacture of pharmaceutical preparations
THIS BUSINESS IN SOCIAL MEDIA
- Google Plus
- Visit
- Twitter
- Follow
LAST EVENTS
- 28 Feb 2017
- Confirmation statement made on 28 January 2017 with updates
- 31 Oct 2016
- Amended total exemption small company accounts made up to 30 September 2015
- 24 Oct 2016
- Registered office address changed from 30 Gay Street Bath Somerset BA1 2PA to Fiveways 57-59 Hatfield Road Potters Bar Hertfordshire EN6 1HS on 24 October 2016
See Also
Last update 2018
NANOPHARM LIMITED DIRECTORS
M S BATH SECRETARIES LIMITED
Acting
PSC
- Appointed
- 30 September 2007
- Role
- Secretary
- Address
- 30 Gay Street, Bath, Avon, United Kingdom, BA1 2PA
- Name
- M S BATH SECRETARIES LIMITED
- Notified On
- 6 April 2016
- Country Registered
- Not Specified/Other
- Nature Of Control
- Has significant influence or control
- Place Registered
- Registrar Of Companies For England And Wales
Mark Rowland Clement
Acting
PSC
- Appointed
- 01 September 2016
- Occupation
- Chairman
- Role
- Director
- Age
- 64
- Nationality
- British
- Address
- Frenchlands House, Ockham Road South, East Horsley, Surrey, United Kingdom, KT24 6SN
- Country Of Residence
- England
- Name
- CLEMENT, Mark Rowland
- Notified On
- 6 April 2016
- Nature Of Control
- Ownership of shares – More than 25% but not more than 50%
Price Robert Prof
Acting
- Appointed
- 13 February 2002
- Occupation
- Scientist
- Role
- Director
- Age
- 54
- Nationality
- British
- Address
- 30 Gay Street, Bath, Somerset, United Kingdom, BA1 2PA
- Country Of Residence
- Wales
- Name
- PRICE, Robert, Prof
Shur Jagdeep Singh Dr
Acting
PSC
- Appointed
- 09 February 2015
- Occupation
- Director
- Role
- Director
- Age
- 45
- Nationality
- British
- Address
- 30 Gay Street, Bath, Somerset, United Kingdom, BA1 2PA
- Country Of Residence
- United Kingdom
- Name
- SHUR, Jagdeep Singh, Dr
- Notified On
- 6 April 2016
- Nature Of Control
- Right to appoint and remove directors
Price Robert Prof
Resigned
PSC
- Appointed
- 13 February 2002
- Resigned
- 30 September 2007
- Occupation
- Scientist
- Role
- Secretary
- Nationality
- British
- Address
- 12 Court House Road, Llanvair Discoed, Chepstow, Gwent, NP16 6LW
- Name
- PRICE, Robert, Prof
- Notified On
- 6 April 2016
- Nature Of Control
- Right to appoint and remove directors
Harold Wayne
Resigned
- Appointed
- 11 February 2002
- Resigned
- 11 February 2002
- Role
- Nominee Secretary
- Address
- Burlington House, 40 Burlington Rise, East Barnet, Hertfordshire, EN4 8NN
- Name
- WAYNE, Harold
Yvonne Wayne
Resigned
- Appointed
- 11 February 2002
- Resigned
- 11 February 2002
- Role
- Nominee Director
- Age
- 44
- Nationality
- British
- Address
- Burlington House, 40 Burlington Rise, East Barnet, Hertfordshire, EN4 8NN
- Country Of Residence
- United Kingdom
- Name
- WAYNE, Yvonne
Paul Michael Young
Resigned
- Appointed
- 13 February 2002
- Resigned
- 30 September 2007
- Occupation
- Scientist
- Role
- Director
- Age
- 50
- Nationality
- British
- Address
- 8 Saint James Parade, Bath, BA1 1UL
- Name
- YOUNG, Paul Michael
REVIEWS
Check The Company
Excellent according to the company’s financial health.
